Fu, Wenyan
591  results:
Search for persons X
?
4

Chronic hypoxia impairs skeletal muscle repair via HIF‐2α s..:

Yin, Amelia ; Fu, Wenyan ; Elengickal, Anthony...
Journal of Cachexia, Sarcopenia and Muscle.  15 (2024)  2 - p. 631-645 , 2024
 
?
8

Antitumor activity of the VEGFR inhibitor ZD6474 in human c..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Wang, Chuqi ; Fu, Wenyan ; Lei, Changhai. - p. 125-129 , 2023
 
?
9

Use of MET kinase inhibitors to overcome cetuximab resistan..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Ma, Zetong ; Fu, Wenyan ; Lei, Changhai. - p. 113-117 , 2023
 
?
10

Overcoming acquired resistance to EGFR-targeted therapy by ..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Qian, Kewen ; Fu, Wenyan ; Hu, Shi - p. 173-177 , 2023
 
?
11

Dual inhibition of EGFR and c-Src by cetuximab and dasatini..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Qian, Kewen ; Fu, Wenyan ; Lei, Changhai. - p. 99-103 , 2023
 
?
12

Four-in-one antibodies have superior cancer inhibitory acti..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Ma, Zetong ; Li, Tian ; Fu, Wenyan.. - p. 55-61 , 2023
 
?
13

Sym004 anti-EGFR antibody mixture overcomes resistance to a..:

, In: Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies,
Li, Guangyao ; Li, Tian ; Fu, Wenyan.. - p. 35-40 , 2023
 
?
15

A SOX9-B7x axis safeguards dedifferentiated tumor cells fro..:

Liu, Yu ; John, Peter ; Nishitani, Kenta...
Developmental Cell.  58 (2023)  23 - p. 2700-2717.e12 , 2023
 
1-15